on 2 Mar 2022
Last Applicant/ Owned by
AMICUS THERAPEUTICS, INC.
3675 Market StreetPhiladelphia, PA 19104
US
Serial Number
2372739 filed on 9th Jun 2020
Registration Number
TMA1121722 registered on 2th Mar 2022
Registration expiry Date
9th Jun 2030Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
Trademark usage description
pharmaceutical preparations for the treatment of pompe disease; pharmaceutical preparations for the treatment of genetic diseases.11
2372739
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 17th Nov 2021 | Approved |
Submitted for opposition 22 on 10th Nov 2021 | Search Recorded |
Submitted for opposition 135 on 6th Oct 2021 | Amendment to Application |
Submitted for opposition 256 on 10th May 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 14th Aug 2020 | Agent Changed |
Submitted for opposition 257 on 9th Jul 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 8th Jul 2020 | Created |
Submitted for opposition 31 on 8th Jul 2020 | Formalized |
Submitted for opposition 30 on 9th Jun 2020 | Filed |
Submitted for opposition 228 on 9th Jun 2020 | International Registration |